LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 2-Month TB treatment be as good as 4 months?
Disease control CompletedThis study tested whether taking a higher dose of the drug rifampin for 2 months is as safe and effective as the standard dose taken for 4 months to treat latent tuberculosis (TB). About 1,368 adults and children aged 10 and older with latent TB took part. The goal was to see if …
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New study aims to protect kids from tuberculosis
Disease control CompletedThis study tested a medicine called rifapentine, combined with isoniazid, to prevent tuberculosis (TB) in children up to 12 years old who had latent TB infection (meaning they carried the TB bacteria but weren't sick). The goal was to find the right dose that works as well in chi…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated May 29, 2026 14:18 UTC